Vito J. Palombella
2021 - Surface Oncology
In 2021, Vito J. Palombella earned a total compensation of $1.2M as Chief Scientific Officer at Surface Oncology, a 7% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $192,000 |
---|---|
Option Awards | $527,768 |
Salary | $428,490 |
Other | $12,756 |
Total | $1,161,014 |
Palombella received $527.8K in option awards, accounting for 45% of the total pay in 2021.
Palombella also received $192K in non-equity incentive plan, $428.5K in salary and $12.8K in other compensation.
Rankings
In 2021, Vito J. Palombella's compensation ranked 8,246th out of 12,415 executives tracked by ExecPay. In other words, Palombella earned more than 33.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,246 out of 12,415 | 34th |
Division Manufacturing | 3,652 out of 5,508 | 34th |
Major group Chemicals And Allied Products | 1,624 out of 2,378 | 32nd |
Industry group Drugs | 1,444 out of 2,099 | 31st |
Industry Biological Products, Except Diagnostic Substances | 320 out of 449 | 29th |
Source: SEC filing on April 26, 2022.
Palombella's colleagues
We found three more compensation records of executives who worked with Vito J. Palombella at Surface Oncology in 2021.